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Abstract 
The development of depression may involve a complex interplay of environmental and 
genetic risk factors. PubMed and PsycInfo databases were searched from inception 
through August 3, 2017, to identify meta-analyses and Mendelian randomization (MR) 
studies of environmental risk factors associated with depression. For each eligible meta-
analysis, we estimated the summary effect size and its 95% confidence interval (CI) by 
random-effects modeling, the 95% prediction interval, heterogeneity with I2, and 
evidence of small-study effects and excess significance bias. Seventy meta-analytic 
reviews met the eligibility criteria and provided 134 meta-analyses for associations from 
1,283 primary studies. While 109 associations were nominally significant (P < 0.05), 
only 8 met the criteria for convincing evidence and, when limited to prospective studies, 
convincing evidence was found in 6 (widowhood, physical abuse during childhood, 
obesity, having 4-5 metabolic risk factors, sexual dysfunction, job strain). In studies in 
which depression was assessed through a structured diagnostic interview, only 
associations with widowhood, job strain, and being a Gulf War veteran were supported 
by convincing evidence. Additionally, 8 MR studies were included and provided no 
consistent evidence for the causal effects of obesity, smoking, and alcohol consumption. 
The proportion of variance explained by genetic risk factors was extremely small (0.1-
0.4%), which limited the evidence provided by the MR studies. Our findings suggest 
that despite the large number of putative risk factors investigated in the literature, few 
associations were supported by robust evidence. The current findings may have clinical 
and research implications for the early identification of individuals at risk for 
depression. 
Keywords: depression; umbrella review; risk factors; meta-analyses; psychiatry; 
prevention  
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1. Introduction 
Major depressive disorder is a leading cause of disability worldwide (Eke et al., 2016) 
and is associated with psychosocial dysfunction (Birnbaum et al., 2010), increased 
health care use (Birnbaum et al., 2010), and excess mortality (Walker et al., 2015). Data 
from the World Mental Health (WMH) Survey indicates that the lifetime prevalence of 
a major depressive episode significantly varies across countries (Bromet et al., 2011). 
 Depression is a complex multi-factorial disorder (Otte et al., 2016), and 
heritability of the broad depression phenotype has been estimated to be approximately 
37% (Flint and Kendler, 2014). Several environmental risk factors have been posited to 
contribute to the development of depression, including but not limited to childhood 
maltreatment (Li et al., 2016), childhood loss of a parent (Bifulco et al., 1987; Harris et 
al., 1986), lack of adequate parental care (Bifulco et al., 1987; Harris et al., 1986; Parker 
et al., 1997), unemployment, lower educational attainment, lower social support, the 
absence of a partner, lower physical activity (Schuch et al., 2016; Schuch et al., 2018), 
and cannabis use (Kessler and Bromet, 2013; Lev-Ran et al., 2014; Otte et al., 2016). 
Emerging evidence also suggests that gene-environment interactions may contribute to 
the development of depressive episodes (Januar et al., 2015), and accumulating 
evidence also indicates that epigenetic mechanisms may play a role in the 
psychopathophysiology of this illness. Although some evidence suggests that the onset 
of depression can be prevented, the field awaits more conclusive data (Munoz et al., 
2010; van Zoonen et al., 2014). 
 The identification of environmental risk factors, some of which could be 
potentially modifiable, may be useful toward designing more targeted and effective 
preventative strategies for depression. Observational studies are used to explore the 
association of an exposure to an outcome but are frequently affected by residual 
confounding, undetected bias, or reverse causality, which may generate unreliable 
associations that are not dependable indicators of causality (Salanti and Ioannidis, 
2009). Mendelian randomization (MR) studies may provide a methodologically sound 
and cost-effective alternative to infer causation while providing an analogy to a 
randomized controlled trial. In those studies, an instrumental variable (often a genetic 
risk score) associated with the exposure was employed, and associations between the 
instrumental variable and outcome (here, depression) are considered to reflect a causal 
effect of the exposure on the outcome if certain assumptions are met. Since MR studies 
largely overcome the problems of confounding and reverse causality, they can provide 
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stronger evidence regarding the causal effect of an environmental risk factor (Gage et 
al., 2013). 
Several systematic reviews and meta-analyses of environmental risk factors for 
depression have been published. In addition, MR experiments have been increasingly 
employed in an attempt to elucidate potential risk factors for depression (Gage et al., 
2013). Nevertheless, no systematic effort has been made to our knowledge to synthesize 
the breadth of the evidence from this composite literature. The umbrella review is a 
systematic review of multiple meta-analyses on a specific research topic (Ioannidis, 
2009) that can be used to provide a wider picture of that extensive literature. We 
therefore performed an umbrella review of meta-analyses and MR studies that 
investigated environmental risk factors for depression. Finally, we also assessed 
whether there are hints of various biases in this literature that may undermine the 
strength or reliability of the evidence. These hints included excess of significance, large 
heterogeneity, and small-study effects. Therefore, associations supported by the 
strongest epidemiologic evidence were identified. 
2. Materials and methods 
2.1. Search strategy and eligibility criteria  
An umbrella review was conducted following an a priori defined protocol (available 
from the authors upon request). We systematically searched the PubMed and PsycInfo 
databases from inception to August 3, 2017, to identify meta-analyses of observational 
studies (i.e., cross-sectional, case-control, and prospective) investigating associations of 
environmental (non-genetic) risk factors for depression. Furthermore, MR studies that 
examined putative environmental risk factors for depression were also included. This 
umbrella review focused on major depressive disorder. Therefore, meta-analyses and 
MR studies that specifically assessed environmental risk factors for perinatal depression 
were excluded, since this is a specific form of depression with distinct features 
(American Psychiatric Association, 2013). Detailed search strings are provided in the 
supplement that accompanies the online version of this article. We included meta-
analyses published in English that assessed one or more environmental factors 
(including other disease conditions) for associations with depression, and that included 
at least 3 datasets (i.e., component studies) and provided some measure of association. 
A diagnosis of depression had to be established through validated structured or semi-
structured interviews based on the Diagnostic and Statistical Manual of Mental 
Disorders (DSM) (American Psychiatric Association, 2013), the International 
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Classification of Diseases (ICD) (World Health Organization, 1993), or other 
consensus-based diagnostic criteria for depression (e.g. the Research Diagnostic 
Criteria) (Endicott and Spitzer, 1979). We also considered studies in which case 
ascertainment for depression was established via a validated screening instrument with a 
cutoff score (e.g., the Beck Depression Inventory, the Patient Health Questionnaire-9, 
and the Zung Self-Rating Depression Scale) and a clinician code-based diagnosis based 
on specific criteria (e.g., ICD). Studies in which the case ascertainment of depression 
was made solely on clinician diagnosis without a specific diagnostic criteria-based code 
were deemed ineligible for inclusion in this umbrella review. 
2.2. Data extraction 
Data extraction was independently conducted by two investigators, and in cases of 
discrepancies, a consensus was reached through mutual discussion. From each eligible 
article, we recorded the first author, journal, year of publication, investigated risk 
factors, and the number of included studies. We also extracted study-specific risk 
estimates (relative risk [RR], odds ratio [OR], hazard ratio [HR], or incident risk ratio) 
with their corresponding 95% confidence intervals (CIs) and the number of cases and 
controls. Whenever the studies included several control groups, we considered 
associations with the healthy control group. The impact of putative risk factors for 
depression may differ across the lifespan (Fiske et al., 2009; Maughan et al., 2013). 
Therefore, we also annotated whether the included meta-analyses primarily synthesized 
evidence for depression in youths (i.e., pediatric depression, age < 18 years) or in older 
adults (late-life depression, age ≥ 55 years). When 2 or more meta-analyses were 
available on the same exposure, we considered the one with the largest number of 
component datasets. Finally, we extracted data from forest plots of meaningful 
subgroup analyses from the original reports when at least 3 datasets were included (e.g., 
analyses limited to prospective studies). For MR studies, we extracted data on the study 
population, sample size, genetic instruments, the variance of the environmental risk 
factor explained by the genetic instruments (R2), and the MR effect estimates (odds 
ratio, hazard ratio, or regression coefficient β). If R2 was missing from the study, but 
other MR studies that used the same genetic variants as instrumental variables provided 
this parameter, we used the R2 values provided by those studies. 
2.3. Methodological quality assessment  
Two authors (CAK and AFC) independently rated the methodological quality of the 
included systematic reviews and meta-analyses with the Assessment of Multiple 
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Systematic Reviews (AMSTAR) instrument, which has been validated for this purpose 
(Pieper et al., 2015; Shea et al., 2007). The scores ranged from 0 to 11 with higher 
scores indicating greater quality. The AMSTAR tool involves dichotomous scoring (i.e., 
0 or 1) of 11 items related to assess the methodological rigor of the systematic reviews 
and meta-analyses (e.g., comprehensive search strategy and/or publication bias 
assessment). The AMSTAR scores were graded as high (8-11), medium (4-7), and low 
quality (0-3) (Shea et al., 2007).  
2.4. Statistical analysis  
We followed established procedures to assess the epidemiological credibility of possible 
risk factors for depression (Belbasis et al., 2015; Bellou et al., 2016; Carvalho et al., 
2016a). First, for each meta-analysis, we recalculated the summary effect size (ES) with 
95% CIs using random-effects modeling (Higgins et al., 2009; Lau et al., 1997) from 
the individual study data provided in the original meta-analysis. We also estimated the 
prediction interval (PI) and its 95% CI, which assesses heterogeneity and evaluates the 
uncertainty of the ES in a new study investigating the same association (Higgins et al., 
2009; IntHout et al., 2016). For the largest dataset in each meta-analysis, the standard 
error (SE) of the effect size was estimated and we examined whether the SE was less 
than 0.10. In a study with SE < 0.10, the difference between the effect size estimate and 
the upper or lower 95% CI was less than 0.20, which is regarded as a small effect size 
(Cohen, 1977). 
 Between-study heterogeneity was assessed using the I2 statistic (Patsopoulos et 
al., 2009). I2 values may range from 0% to 100% and quantify the variability in the 
effect size estimates that was due to heterogeneity rather than sampling error (Higgins 
and Thompson, 2002). Values exceeding 50% and 75% indicated large and very large 
heterogeneity, respectively.  
 We also assessed the small-study effects (i.e., whether smaller studies had a 
tendency to provide more robust effect sizes compared to larger ones) using the Egger’s 
regression asymmetry test (Egger et al., 1997). A P < 0.10 combined with a more 
conservative effect size in the largest study rather than in the summary effect size of the 
random-effects meta-analysis was judged to provide evidence of the small-study effects 
(Carvalho et al., 2016b).  
 We also applied the excess of significance test, which determines whether there 
is a relative excess of formally significant findings in the published literature due to 
publication bias, selective reporting of outcomes or analyses, or other reasons. This is a 
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χ
2
 test that assesses whether the observed (O) number of nominally significant findings 
is larger than their expected (E) number (Ioannidis, and Trikalinos, 2007). We used the 
effect size of the largest study in each meta-analysis to calculate the power of each 
study using a non-central t distribution (Ioannidis, 2013; Lubin and Gail, 1990). 
Evidence of excess of significance was claimed when E > O and two-tailed P < 0.10 as 
previously proposed (Ioannidis and Trikalinos, 2007).  
 For meta-analyses with type I or II evidence (see below) sensitivity analyses 
were conducted considering (1) only prospective studies and (2) studies in which 
depression was diagnosed with a structured or semi-structured diagnostic interview as 
opposed to studies in which the ascertainment of cases was established through a 
screening instrument. Data from at least 3 datasets were required to perform these 
analyses.  
 Finally, for associations supported by type I or type II evidence, we used 
credibility ceilings, a sensitivity analysis tool, to account for potential methodological 
limitations of the included studies (e.g., poor controlling of confounders, recall and 
interviewer bias, and lack of comparability between the exposed and control groups), 
which might lead to spurious precision of the combined effect size estimates (Salanti 
and Ioannidis, 2009). This method assumes that every observational study has a 
probability c (credibility ceiling) that the true effect size is in a different direction from 
the one indicated by its point estimate. The pooled effect sizes were estimated for a 
wide range of credibility ceilings (Kyrgiou et al., 2017; Salanti and Ioannidis, 2009).  
For the MR studies, we present a descriptive analysis of the eligible studies. If 
all of the information required for calculation was available (i.e. sample size, number of 
cases, R2, estimates of association, and measure of association), we performed a power 
calculation for the largest MR study using the non-centrality parameter-based approach 
(Li et al., 2017). Statistical analysis and power calculations were performed using 
STATA version 12.0. 
2.5. Assessment of epidemiologic credibility  
The level of epidemiologic credibility for each environmental risk factor was rated in 
accordance with pre-established criteria: I (convincing evidence), II (highly suggestive 
evidence), III (suggestive evidence), IV (weak evidence), and NS (all associations had 
non-significant findings). This set of criteria was used in similar efforts to synthesize 
evidence of environmental risk factors for other neuropsychiatric disorders (Belbasis et 
al., 2015; Bellou et al., 2016; Bortolato et al., 2017). In brief, evidence was rated as 
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convincing evidence when all of the following criteria were met: statistical significance 
according to random effects models at P < 10-6; included more than 1000 cases; lack of 
large between-study heterogeneity (I2 < 50%); 95% PI excluding the null value; and no 
evidence of small-study effects and excess significance. Other associations with more 
than 1,000 cases, P < 10-6, and the largest study presenting a statistically significant 
effect were graded as highly suggestive evidence. Other associations supported by > 
1,000 cases and a significant effect at P < 10-3 were rated as suggestive evidence, while 
all remaining nominally significant associations (at P < 0.05) were considered as having 
weak evidence. 
3. Results 
3.1. Overall assessment of meta-analyses  
Overall, the title and abstracts of 5,869 unique references were evaluated for eligibility 
(Figure 1), while full texts of 460 references were scrutinized for eligibility. Finally, 
382 references were excluded after full-text review with reasons (Supplementary Table 
S1, available online), leaving 78 unique references that met the eligibility criteria (70 
references were meta-analytic reviews and the remaining 8 were MR studies).  
 Data from 1,283 original studies that assessed 89 different associations of 
environmental risk factors for depression (Table 1), 6 unique associations with pediatric 
depression (Table S3, available online), and 39 putative associations with late-life 
depression (Table 2) were obtained from the 70 meta-analytic reviews. Therefore, 134 
different associations of risk factors for depression were identified and examined 
through meta-analysis. The median number of datasets included in the meta-analyses 
was 7.5 (IQR: 5-11), and the number of cases was > 1,000 in 56 (41.8%) meta-analyses. 
The heterogeneity was large (I2 > 50%) in 76 (56.7%) meta-analyses, while 24 (17.9%) 
meta-analyses exhibited evidence of small-study effects. Excess of statistical 
significance could not be calculated for 29 (21.6%) meta-analyses (Chang-Quan et al., 
2010a; Chang-Quan et al., 2010b; Grosso et al., 2016; Hasan et al., 2015; Huang et al., 
2010; Lorant et al., 2003; Luger et al., 2014; Ttofi et al., 2011; Wang et al., 2016; Xiu-
Ying et al., 2012; Yan et al., 2011; Zhai et al., 2015), and this type of bias was observed 
in 17 (12.7%) meta-analyses (Bonde et al., 2016; Cole and Dendukuri, 2003; Huang et 
al., 2010; Osborn et al., 2014; Pan et al., 2012; Parsaik et al., 2014; Rahe et al., 2014; 
Zhao et al., 2012). The overall methodological quality of the included meta-analyses 
was medium (median AMSTAR score: 6; IQR: 5-7). Table S2 (available online) 
provides scores for each included meta-analysis.  
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<Please insert Figure 1 here>  
<Please insert Table 1 here>  
<Please insert Table 2 here>  
3.2. Environmental risk factors for depression  
Of 89 associations of environmental risk factors for depression in adults (age ≥ 18 
years), 68 (77.3%) were nominally significant (P < 0.05). These associations pertained 
to dietary factors (number of associations, k = 18), drugs/substances (k = 3), family 
factors (k = 2), habits/lifestyle factors (k = 6), infections (k = 6); medical history and 
comorbid diseases (k = 14), obesity and metabolic abnormalities (k = 17), pregnancy 
and birth-related factors (k = 3), socio-demographic factors (k = 10), and exposure to 
trauma/disasters (k = 10) (Table 1). Only 8 associations were supported by type I 
evidence: obesity, exposure to physical abuse in childhood, the presence of 4-5 
metabolic risk factors, tea intake, sexual dysfunction, job strain, widowhood, and 
dietary zinc (Figure 2). However, in a sensitivity analysis in which only prospective 
studies were considered, obesity, exposure to physical abuse in childhood, the presence 
of 4-5 metabolic risk factors, sexual dysfunction, job strain, and widowhood remained 
supported by type I evidence, while the association with tea intake was no longer 
statistically significant, and only 2 studies found an association with zinc intake (Table 
S4, available online). In a sensitivity analysis where only studies in which a case 
definition of depression was established using a structured diagnostic interview as 
opposed to studies that used screening instruments were considered, only job strain and 
widowhood remained supported by type I evidence (Table S5, available online), while 
sexual dysfunction dropped to type II evidence (after the PI crossed the null and 
evidence of small-study effects emerged). Exposure to physical abuse was now 
supported by weak evidence after the number of cases dropped to less than 1,000 (Table 
S5, available online). Fewer than 3 independent studies in which a structured diagnostic 
interview was used to assess depression were available for obesity (k = 2 studies), the 
presence of 4-5 metabolic risk factors (k = 2), tea intake (k = 1), and dietary zinc (k = 
1). Thus, sensitivity analyses were not performed.  
Finally, all environmental risk factors with the exception of job strain survived 
10% credibility ceilings, while obesity, exposure to physical abuse in childhood, and the 
presence of 4-5 metabolic risk factors remained nominally significant when 20% 
credibility ceilings were considered (Table S6, available online).  
<Please insert Figure 2 here>  
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 Furthermore, 9 associations were supported by type II evidence: intimate partner 
violence against women, co-occurring psoriasis, the metabolic syndrome, the presence 
of 3 metabolic risk factors, sedentary behavior, being a Gulf War veteran, exposure to 
sexual abuse during childhood, exposure to emotional abuse during childhood, and dry 
eye disease with Sjögren’s syndrome (Table 1). When only prospective studies were 
considered, associations with the presence of 3 metabolic risk factors and exposure to 
physical abuse during childhood remained supported by type II evidence, while 
associations with exposure to emotional abuse during childhood dropped to type III 
evidence after the significance level was between 10-6 and 10-3, and the association with 
metabolic syndrome dropped to weak as the significance was higher than 10-3 (Table S4, 
available online). When the sensitivity analysis considered only studies in which a 
diagnosis of depression was established through a structured diagnostic interview, then 
associations with being a Gulf War veteran was supported by type I evidence whereas 
associations with intimate partner violence against women, co-occurring psoriasis, and 
the presence of 3 metabolic risk factors remained supported by type II evidence (Table 
S5, available online). Associations with exposure to sexual abuse during childhood 
dropped to type III evidence, while associations with exposure to emotional abuse 
during childhood were supported by weak evidence after changes in the significance 
level (Table S5, available online). In addition, associations with metabolic syndrome 
were no longer nominally significant, while a sensitivity analysis could not be 
performed for the presence of 3 metabolic risk factors, sedentary behavior, and the 
presence of dry eye with Sjögren’s syndrome because fewer than 3 independent studies 
were available (Table S5, available online). Finally, all associations supported by type II 
evidence remained nominally significant when 10% credibility ceilings were considered 
(Table S6, available online). 
3.3. Environmental risk factors for pediatric depression  
Six environmental risk factors for depression in youths have been examined through 
meta-analyses. The presence of co-occurring asthma was supported by type II evidence 
(Lu et al., 2012). No sensitivity analysis considering only prospective studies or studies 
in which depression was assessed using a structured diagnostic interview could be 
performed for this association because fewer than 3 independent studies were available. 
Any childhood maltreatment and obesity were supported by type III evidence. The 
remaining associations, namely smoking and childhood chronic illnesses (cancer or 
diabetes), were not statistically significant (Table S3, available online). The association 
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with co-occurring asthma remained nominally significant at 10% credibility ceilings, 
but was no longer significant at 20% credibility ceilings (Table S6, available online).  
3.4. Environmental risk factors for late-life depression  
Thirty-nine associations of environmental risk factors for late-life depression were 
examined across 10 included articles (Table 2) pertaining to dietary factors (k = 2), 
family factors (k = 1), medical history and comorbid diseases (k = 20), obesity and 
metabolic factors (k = 2), socio-demographic factors (k = 13), and exposure to trauma 
and disasters (k = 1). No association was supported by type I evidence, although poor 
health status, presence of a chronic disease, poor vision, low educational level, and 
sleep disturbances were supported by type II evidence (Figure 2). However, when only 
prospective studies were considered, associations with the presence of a chronic disease 
were then supported by type III evidence, while the association with a low educational 
level was supported by weak evidence after changes in the significance level (Table S4, 
available online). Only the association with sleep disturbances remained supported by 
type II evidence whereas a sensitivity analysis limited to prospective studies could not 
be conducted for associations with poor health status or poor vision because fewer than 
3 component datasets were available (Table S4, available online). Furthermore, when 
only studies in which a diagnosis of depression was established through a structured 
diagnostic interview were considered, associations with educational level and poor 
health status were then supported by weak evidence because the number of cases 
dropped to less than 1,000, while the association with sleep disturbances was supported 
by type III evidence after changes in the significance level (Table S5, available online). 
Furthermore, all associations that were supported by type II evidence remained 
nominally significant when 20% credibility ceilings were considered (Table S6, 
available online). 
3.5. Mendelian randomization studies 
Ten MR analyses were identified from 8 publications (Table 3). The median number of 
participants was 9,240 (range: 2,404-82,608) and the median number of cases was 2,430 
(range: 610-9,519). Six unique environmental risk factors (Table 3) were investigated in 
individual MR studies: smoking, alcohol consumption, obesity, body mass index (BMI), 
age of menarche, and coffee consumption. The proportion of variance in risk factors 
(R2) explained by genetic instruments was 0.1-0.4%. These small values limit the 
evidence derived from MR studies. More than one MR study was identified for 2 
outcomes (tobacco smoking and alcohol consumption), and four studies used more than 
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one genetic variable (Table 3). Discordance in either the direction and/or statistical 
significance of associations among overlapping MR investigations existed for alcohol 
consumption and smoking. Age of menarche presented significant associations at P < 
0.05 for one among multiple analyses for only some quartiles (Sequeira et al., 2017). 
Body mass index association was investigated using several MR methods (Hartwig et 
al., 2016), but only the weighted median method showed a statistically significant 
association at the P = 0.05 level (OR = 1.40; 95% CI = 1.03-1.90).  
4. Discussion 
We systematically collected and appraised putative environmental risk factors for 
depression that have been examined in meta-analyses of observational studies. While 
this effort identified 134 associations with depression, including 6 specific associations 
with pediatric depression and 39 associations with late-life depression, only nine 
associations met the criteria for convincing evidence (significant at the 10-6 level by 
random-effects meta-analysis, more than 1,000 cases, 95% PI not crossing the null, no 
small-study effects, small heterogeneity, and no excess of significance). These risk 
factors included obesity (Jokela et al., 2014), the presence of 4-5 metabolic risk factors 
(Jokela et al., 2014), widowhood (Onrust and Cuijpers, 2006), sexual dysfunction 
(Atlantis and Sullivan, 2012), tea consumption (Dong et al., 2015), exposure to physical 
abuse during childhood (Mandelli et al., 2015), job strain (Madsen et al., 2017), dietary 
zinc intake (Li et al., 2017), and being a Gulf War veteran (Blore et al., 2015). The latter 
association was supported by convincing evidence only when the analysis was limited 
to studies in which the case definition of depression was performed through a structured 
or semi-structured diagnostic interview. Fifteen environmental risk factors were 
supported by highly suggestive evidence in the main analysis (i.e., the random-effects 
meta-analysis was significant at the 10-6 level, more than 1,000 cases, the confidence 
interval of the largest study did not cross the null, and at least one of the following was 
present: large heterogeneity, PI crossing the null, excess of significance, or small-study 
effects). These included intimate partner violence against women (Beydoun et al., 
2012), metabolic syndrome (Pan et al., 2012), being a Gulf War veteran (Blore et al., 
2015), the presence of 3 metabolic risk factors (Jokela et al., 2014), sedentary behavior 
(Zhai et al., 2015), co-occurring psoriasis (Dowlatshahi et al., 2014), exposure to 
emotional abuse during childhood (Mandelli et al., 2015), exposure to sexual abuse 
during childhood (Mandelli et al., 2015), and dry eye disease with Sjögren’s syndrome 
(Wan et al., 2016). In addition, co-occurring asthma was supported by type II evidence 
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as a risk factor for pediatric depression (Lu et al., 2012). Finally, associations with poor 
health status (Chang-Quan et al., 2010a), the presence of a chronic disease (Chang-
Quan et al., 2010a), poor vision (Huang et al., 2010), lower educational attainment 
(Chang-Quan et al., 2010a), and sleep disturbances (Bao et al., 2017) were supported by 
highly suggestive evidence as risk factors for late-life depression.  
4.1. Associations of environmental risk factors for depression supported by evidence 
 Despite the substantial number of associations with convincing or highly 
suggestive evidence in different analyses, very few factors maintained convincing 
evidence when the data were limited to prospective studies or those with structured 
diagnostic interviews. Overall, from the 23 associations supported by at least highly 
suggestive evidence, 15 could not be analyzed in both sensitivity analyses due to the 
lack of prospective design or studies using structured diagnostic interviews as diagnosis 
instruments. Only 118 of the 257 studies investigating these associations were 
prospective. Therefore, many of these associations should be interpreted with caution. 
 Most of the factors identified with convincing or highly suggestive evidence 
were stressors. It is speculated that stressors contribute to the emergence of depression 
by altering the brain circuits, for example in the amygdalae, which are involved in mood 
regulation (McEwen, 2003). However, it is unclear why some stressors, but not others, 
exhibited more convincing associations with depression. It is worth noting that exposure 
to stressors may also contribute to the bidirectional associations between depression and 
several chronic disease states through the generation of allostatic overload, which 
results from the chronic exposure to fluctuating or heightened neural or neuroendocrine 
responses associated with stress exceeding the coping resources of an individual (Fava 
et al., 2010). 
 In particular, we found convincing evidence that exposure to physical abuse 
during childhood was a risk factor for depression (Mandelli et al., 2015). Physical abuse 
is physical harm perpetrated by a child’s caregiver, including hitting, pinching, kicking, 
biting, burning, poisoning, or suffocating the child. These findings are consistent with 
the view that during critical periods of brain development, exposure to trauma may 
permanently influence brain function and response to stressors later in life via several 
mechanisms (Ignacio et al., 2016; Lopizzo et al., 2015; Post and Weiss, 1998). 
However, it should be noted that the epidemiological credibility of those findings 
decreased when sensitivity analyses were limited to studies in which depression was 
assessed through structured diagnostic interviews. Evidence suggests that the severity of 
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depression occurs on a continuum ranging from depressive symptoms captured with a 
validated questionnaire or a structured clinical diagnosis (Cuijpers and Smit, 2004; 
Prisciandaro and Roberts, 2009). Notwithstanding that structured diagnostic interviews 
are considered “gold standards” to ascertain a diagnosis of a mental disorder for 
research purposes, there are also inherent limitations in this approach (Nordgaard et al., 
2013). Nevertheless, associations in which the epidemiological robustness of evidence 
does not survive sensitivity analysis restricted to studies in which the case definition of 
depression is established through structured diagnostic interviews should be interpreted 
with caution and may require further elucidation. 
 Exposure to childhood maltreatment may also have deleterious systemic 
consequences. It has been argued that exposure to trauma early in life may be associated 
with several deleterious health outcomes later in life, some of which may be relevant to 
the emergence of depressive episodes (Nemeroff, 2016). We found highly suggestive 
evidence that women exposed to intimate partner violence may have a higher risk of 
developing depression. Notwithstanding variations across cultures that should be 
acknowledged (Kessler and Bromet, 2013), most research points to a higher prevalence 
of depression among women. The mechanisms explaining a greater likelihood to 
develop depression among women appear complex (Kuehner, 2016), but a higher 
gender-specific exposure to certain stressors may play a role.  
 We also found convincing evidence that being a Gulf War veteran is associated 
with an increased risk of depression when studies that used a structured diagnostic 
interview for depression were considered (k = 4 studies). This is consistent with the 
diathesis-stress model of depression, which posits that exposure to more extreme 
stressors confers an elevated risk of depression (Booij et al., 2013). Finally, it is worth 
noting that depression could be conceived as a “pathoplastic” syndrome (Keller et al., 
2007), in which exposure to different types of stressors could shape symptom 
expression, further contributing to the heterogeneity of the phenotype (Hu et al., 2016; 
Keller et al., 2007). However, this association was largely driven from cross-sectional 
studies, and thus prospective research is warranted. 
 We found evidence that obesity and the presence of 4-5 metabolic risk factors 
may increase the risk of developing depression (Jokela et al., 2014). Several 
mechanisms may contribute to this association, including speculated higher peripheral 
inflammation (de Melo et al., 2017; Kohler et al., 2017; Liu et al., 2014; Mansur et al., 
2015). The concept of “metabolic” depression has been proposed, although the 
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epidemiological evidence remains modest (Liu et al., 2014; Mansur et al., 2015). The 
association of obesity and metabolic risk factors with depression may simply suggest 
that both conditions share common environmental risk factors. It is worth noting that 
this pooled analysis of 8 large-scale cohort studies provided convincing evidence for an 
association between obesity and depression (Jokela et al., 2014). However, we observed 
that the association between obesity and depression was supported only by weak 
evidence when data from a previous meta-analysis of 8 published cohort studies were 
considered (Luppino et al., 2010). In addition, an included MR study did not provide 
evidence of a causal association of obesity as a risk factor for depression (Huang et al., 
2010), although we could not estimate the statistical power of this study, and another 
MR study on the association between BMI and depression provided inconsistent results 
(Hartwig et al., 2016). Two meta-analyses of prospective studies indicated that 
adherence to either traditional healthy dietary patterns or to a Mediterranean-type diet 
could prevent the onset of depression (Rahe et al., 2014). However, these associations 
were supported by weak evidence. Therefore, although several mechanisms may 
contribute to potential protective effects of a healthy diet for both depression and its 
associated metabolic comorbidities, including interactions with the microbiome 
(Slyepchenko et al., 2017), more well-designed studies including randomized controlled 
trials are warranted. 
 The evidence that tea consumption and dietary zinc intake may protect against 
the development of depression should viewed with caution. Several biological 
mechanisms may at least in part explain the association of tea consumption and 
depression (Garcia-Blanco et al., 2016). For example, epigallocatechin gallate, a 
component of green tea, may have antioxidant effects (Han et al., 2014), while certain 
flavanols derived from green tea were shown to increase hippocampal brain-derived 
neurotrophic factor (BDNF) and monoamine levels (Stringer et al., 2015). However, 
this association was not significant in a sensitivity analysis restricted to prospective 
studies and there were insufficient data assessing the association of zinc with depression 
in prospective studies. Furthermore, other lifestyle and dietary factors may confound 
this association as suggested by the authors of the included meta-analysis (Dong et al., 
2015). Associations between single nutrients and outcomes in retrospective studies can 
be notoriously unreliable, even when the published data seem consistent (Schoenfeld 
and Ioannidis, 2013). Therefore, further prospective studies are warranted to assess this 
association. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
17 
 
 The same caveats exist for the observed association between zinc and 
depression. Several lines of evidence have suggested an emerging role for zinc in the 
pathophysiology of depression (Petrilli et al., 2017). For example, peripheral levels of 
zinc are lower in individuals with MDD compared to healthy controls (Swardfager et 
al., 2013), while zinc may exert pleiotropic effects including anti-inflammatory effects, 
modulatory effects on the glutamatergic N-methyl-D-aspartate (NMDA) receptor, and 
neurotrophic effects, which could be relevant for the pathophysiology of depression 
(Petrilli et al., 2017). However, a recent meta-analysis found that controlled trials that 
have tested adjunctive zinc for the treatment of depression have provided mixed results 
(Sarris et al., 2016). Furthermore, a sensitivity analysis limited to prospective studies 
could not be performed as only 2 studies were available from the included meta-analysis 
(Madsen et al., 2017). Therefore, further evidence from prospective studies and 
controlled trials are needed to provide more consistent causal inferences for this 
association. 
 Several putative sociodemographic risk factors for depression have been 
examined in meta-analyses. We found convincing evidence that widowhood as opposed 
to all other types of marital status was significantly associated with depression. 
However, prospective data does not necessarily rule out reverse causation or 
confounders. For example, it could be argued that depression prevents remarriage. In 
addition, type II evidence indicated that a lower educational attainment was associated 
with a higher risk of late-life depression. These findings are broadly consistent with 
large-scale cross-cultural findings (Kessler and Bromet, 2013). However, there were 
variations across different countries (Bromet et al., 2011). In addition, a recent large-
scale study confirmed that lower educational attainment was associated with depression 
(Peyrot et al., 2015). Furthermore, this study found no pleiotropic genetic effects 
mediating this association, thus suggesting that environmental factors are more likely 
involved. 
 Convincing evidence also indicates that sexual dysfunction is associated with 
depression, and this finding survived sensitivity analysis restricted to prospective 
studies. An accumulating body of evidence has pointed to reciprocal interactions 
between sexual dysfunction and depression (de Abreu Barata, 2017). Hence, sexual 
dysfunction may be either a manifestation of depression or a troublesome side effect 
associated with the use of antidepressant drugs (Carvalho et al., 2016c).  
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 According to the job strain theory, work-related stress result from the additive 
effects of high job demands and low job control (Karasek et al., 1988). Convincing 
evidence indicates that job strain is a risk factor for depression, and the same level of 
evidence remained after sensitivity analysis restricted to either prospective studies or 
studies in which depression was assessed through structured diagnostic interviews. 
However, all of the included studies were conducted in Europe and Canada (Madsen et 
al., 2017), and thus the extent to which those findings apply to other countries (for 
example, low- and middle-income countries) deserves further investigation. In addition, 
the studies did not adjust for baseline depressive symptoms or a history of clinical 
depression, and the definition of job strain varied across studies. Considering that job 
strain across the included studies was assessed through self-reported instruments, one 
cannot rule out the possible influence of the participants’ affective states on the 
reporting of work conditions. Furthermore, reverse causality is possible since the 
evidence suggests that depression is associated with a significant detrimental impact on 
work productivity (Broadhead et al., 1990; McIntyre et al., 2015; Stewart et al., 2003). 
4.2. Assessment of bias in the literature on environmental risk factors for depression 
First, our analyses included assessment of several hints of bias, but did not 
provide definitive proof thereof (Ioannidis et al., 2007; Ioannidis and Trikalinos, 2007). 
Evidence of high heterogeneity was observed in 56.4% of eligible meta-analyses. There 
are clear limitations when interpreting Egger’s test, which provides an indication of 
small-study effects in the context of large heterogeneity (Sterne et al., 2011). A high 
degree of heterogeneity across studies in a meta-analysis may constitute an indication of 
bias, which may hinder the interpretation of otherwise statistically significant 
associations. Nevertheless, it is possible that genuine heterogeneity exists across studies. 
Several lines of evidence indicate that genuine heterogeneity might operate in 
depression research. First, significant cross-cultural differences have been reported in 
the prevalence of depression (Bromet et al., 2011; Kessler and Bromet, 2013), which 
may be partly due to varying levels of exposure to risk factors. For example, large 
variability of the conditional prevalence of a major depressive episode considering 
participants who screen positive for depression appeared when data from different 
countries in the WMH survey were compared (Bromet et al., 2011). In addition, 
depression is a heterogeneous phenotype with several subtypes (Hasler et al., 2004; 
Lichtenberg and Belmaker, 2010), and this heterogeneity might have also complicated 
the search for significant genetic variants for depression (Direk et al., 2016; Flint and 
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Kendler, 2014). Furthermore, our sensitivity analyses suggest that study design and case 
definition through a screening tool compared to a structured diagnostic interview could 
assess the evaluation of some associations. Selective use of different cutoff points may 
bias accuracy estimates of screening instruments for depression, even if these 
instruments are regarded as validated measures (Levis et al., 2017), while this limitation 
is not evident in gold-standard structured diagnostic interviews for depression. 
4.3. Strengths and limitations 
Some caveats should be considered when interpreting our analyses. First, as 
previously mentioned, our analyses are not definitive proof of the identified biases. 
Second, the methodological quality of the meta-analyses varied; they were on average 
of medium quality. Third, some potential risk factors for depression that have not yet 
been subjected to meta-analyses might have been missed. These include some risk 
factors that have been classically related to depression, namely childhood loss of a 
parent (Bifulco et al., 1987; Harris et al., 1986), poor parenting style (Parker et al., 
1997), lack of social support, and social adversity (Bruce, 2002). Furthermore, the 
absence of a meta-analytic investigation of an environmental factor does not mean that 
the environmental factor is unimportant, and environmental factors that are more 
difficult to assess may not yet have sufficient information. Finally, evidence from MR 
studies that assessed putative environmental risk factors for depression remains largely 
negative or inconclusive. For example, two MR studies provided no evidence of a 
causal association of alcohol consumption and depression (Almeida et al., 2014; Wium-
Andersen et al., 2015b). Nevertheless, our analyses indicate that both investigations 
were underpowered. Allowing for these caveats, the main strengths of this work rest on 
the topical comprehensiveness of the search, the inclusion of a large body of evidence, 
and the systematic quantitative and qualitative approaches used to rate the quality of the 
available evidence.  
4.4. Implications 
 Convincing associations with strong effect sizes may aid in the identification of 
high-risk populations, regardless of whether or not they are causal. Preventive efforts 
could be targeted to high-risk populations including children exposed to physical abuse, 
military personnel exposed to combat, recently widowed adults, obese individuals, and 
people with 4-5 five metabolic risk factors. This perspective is relevant considering 
recent evidence that suggests that depression can be prevented in youths (Merry et al., 
2011), adults (van Zoonen et al., 2014), and the elderly (Cuijpers et al., 2015). In 
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addition, a better organization and integration of services could enable the early 
recognition and management of depression in these populations. For example, a better 
integration of primary health care services and specialized mental health services could 
potentially aid in the recognition and treatment of depression among high-risk veterans 
(Ashrafioun et al., 2016). In addition, some evidence indicates that collaborative care 
interventions could improve outcomes among patients with depression and co-occurring 
obesity or with several metabolic risk factors (Katon et al., 2010; Panagioti et al., 2016). 
Moreover, this umbrella review indicates that several possible risk factors deserve 
proper meta-analytic assessment.  
4.5. Conclusion 
This umbrella review mapped the status of 134 putative associations of environmental 
risk factors for depression across the lifespan. The findings show that despite the large 
number of putative risk factors investigated in the literature, few associations were 
supported by convincing evidence. Moreover, MR studies, which could provide a more 
stringent control for potential confounders, and hence, in theory, more robust causal 
inferences pertaining to environmental risk factors for depression, remain scarce and 
provided no convincing evidence. The adoption of reporting guidelines (e.g., 
Strengthening the Reporting of Observational Studies in Epidemiology [STROBE]) 
(Vandenbroucke et al., 2007) and a pre-registration of protocols of hypothesis-testing 
observational studies might advance the availability of higher quality evidence in this 
field (Dal-Re et al., 2014). These efforts may aid in the identification of at-risk 
populations who could benefit from targeted preventative strategies. 
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Figure Legends 
 
Fig. 1. Flowchart of the study selection. 
 
Fig. 2. Forest plot depicting the effect sizes (relative risks or odds ratios) and 95% 
CIs of the environmental risk factors for depression supported by type I or type II 
evidence. Only the primary analyses are presented. See the text for sensitivity analyses. 
The underlined associations were supported by type I or type II evidence in the 
prospective studies, and the associations in italics were supported by type I or type II 
evidence in the studies using a structured interview for depression diagnosis. #The 
association of being a Gulf War veteran was supported by type I evidence in studies in 
which depression was assessed through a structured diagnostic interview. Other 
highlighted associations were supported by the same type of evidence.  
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Table 1. Characteristics, assessment of epidemiological credibility, and methodological quality assessment of the 88 eligible meta-analyses of environmental 
risk factors for depression 
Reference Risk factor 
Total number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 
95% PI I2 
Small-
study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Dietary factors 
Anglin, 2013  Vitamin D deficiency 
(prospective studies) 
NA 3 HR 2.22 (1.42-3.47) > 10-6 but < 10-3 0.05-92.87 19 No/No III 9 
Anglin, 2013  Vitamin D deficiency  NA 9 OR 1.31 (1.00-1.71) 0.047 0.63-2.73 53 No/No Weak 9 
Rahe, 2014  Western/unhealthy dietary 
patterns 
NA 9 RR 1.18 (0.97-1.43) 0.096 0.68-2.06 62 No/No NS 5 
Liu, 2016  Vegetable intake NA 7 RR 0.87 (0.77-0.97) 0.014 0.68-1.11 26 Yes/No Weak 5 
Liu, 2016  Fruit intake NA 8 RR 0.85 (0.77-0.93) > 10-6 but < 10-3 0.67-1.07 42 Yes/No III 5 
Grosso, 2016  EPA + DHA intake NA 4 RR 0.85 (0.70-1.04) 0.123 0.43-1.72 38 No/NE NS 5 
Li, 2016  Dietary magnesium NA 10 RR 0.83 (0.73-0.95) 0.006 0.59-1.16 68 Yes/NE Weak 7 
Li, 2016  Fish consumption (highest 
vs lowest) 
1113/496 17 RR 0.83 (0.69-1.01) 0.057 0.42-1.63 72 No/Yes NS 7 
Grosso, 2016  Total n-3 PUFA intake NA 9 RR 0.82 (0.69-0.97) 0.021 0.55-1.22 36 No/NE Weak 5 
Rahe, 2014  Traditional/healthy dietary 
patterns 
NA 17 RR 0.76 (0.68-0.86) > 10-6 but < 10-3 0.50-1.17 79 Yes/Yes III 5 
Rahe, 2014  Mediterranean dietary 
patterns 
NA 4 RR 0.76 (0.64-0.91) 0.002 0.39-1.51 57 No/No Weak 5 
Wang, 2016  Coffee intake NA 4 RR 0.71 (0.52-0.99) 0.044 0.25-2.02 28 No/NE Weak 4 
Dong, 2015  Tea intake 4373/19174 13 RR 0.68 (0.61-0.77) < 10-6 0.49-0.95 42 No/No I 7 
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Reference Risk factor 
Total number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 95% PI I
2
 
Small-
study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Psaltopoulou, 2013  High adherence to 
Mediterranean diet 
2951/15223 9 OR 0.68 (0.54-0.86) 0.001 0.37-1.26 50 No/No Weak 7 
Li, 2017  Dietary zinc 3708/16133 8 RR 0.65 (0.57-0.75) < 10-6 0.55-0.77 0 No/NE I 6 
Wang, 2016  Caffeine intake NA 7 RR 0.65 (0.33-1.29) 0.219 0.05-7.75 97 No/NE NS 4 
Li, 2016  Dietary calcium NA 5 RR 0.64 (0.38-1.08) 0.097 0.12-3.32 61 No/NE NS 7 
Li, 2017  Iron intake 1045/5809 3 RR 0.40 (0.24-0.65) < 0.001 0.00-87.36 63 No/No III 6 
Drugs/Substances 
Lev-Ran, 2014  Heavy cannabis use NA 5 OR 1.43 (1.00-2.04) 0.051 0.54-3.75 36 No/No NS 7 
Lev-Ran, 2014  Cannabis use NA 6 OR 1.17 (0.97-1.41) 0.102 0.73-1.86 37 No/No NS 7 
Parsaik, 2014  Statins use NA 7 OR 0.68 (0.52-0.89) 0.005 0.33-1.41 55 Yes/Yes Weak 7 
Family factors 
Onrust, 2006  Widowhood (vs any other 
marital status) 
2720/4868 5 RR 5.59 (3.79-8.23) < 10-6 2.09-14.97 30 No/No I 3 
Beydoun, 2012  Intimate partner violence 
against women 
3003/21569 9 RR 2.57 (2.25-2.94) < 10-6 2.18-3.02 0 Yes/No II 4 
Habits/Lifestyle            
Ho, 2014  Internet addiction 857/6842 5 OR 2.77 (2.04-3.75) < 10-6 1.09-7.02 56 No/No Weak 5 
Luger, 2014  Smoking NA 77 OR 1.68 (1.55-1.82) < 10-6 0.91-3.10 95 Yes/NE Weak 4 
Zeng, 2016  Secondhand smoke 
exposure 
NA 7 OR 1.60 (1.35-1.90) < 10-6 0.94-2.72 90 No/NE Weak 7 
Zhai, 2015  Long sleep duration NA 5 RR 1.41 (1.04-1.92) 0.026 0.86-2.32 0 No/NE Weak 7 
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Reference Risk factor 
Total number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 95% PI I
2
 
Small-
study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Zhai, 2015  Sedentary behavior 60526/148346 24 RR 1.25 (1.16-1.35) < 10-6 0.97-1.60 51 No/No II 7 
Zhai, 2015  Short sleep duration NA 6 RR 1.25 (0.96-1.62) 0.095 0.86-1.81 0 No/NE NS 7 
Infections 
Wang, 2014  Borna disease virus (BDV) 
infection 
205/2654 15 OR 3.25 (1.62-6.54) > 10-6 but < 10-3 0.48-21.92 46 No/No Weak 7 
Wang, 2014  Varicella zoster virus 71/164 3 OR 2.10 (1.02-4.33) 0.045 0.02-229.62 0 No/No Weak 7 
Wang, 2014  Epstein-Barr virus 295/178 4 OR 1.98 (1.20-3.28) 0.008 0.66-5.99 0 No/No Weak 7 
Wang, 2014  Herpes simplex virus 
(HSV-1, HHV-1) 
295/178 4 OR 1.98 (1.20-3.28) 0.008 0.66-5.99 0 No/No Weak 7 
Wang, 2014  Cytomegalovirus 100/135 3 OR 1.94 (0.91-4.14) 0.086 0.01-262.27 0 No/No NS 7 
Wang, 2014  Toxoplasma gondii 40/272 3 OR 1.46 (0.62-3.43) 0.381 0.01-367.24 0 No/No NS 7 
 
 
Medical history and comorbid diseases 
Wan, 2016  Dry eye disease with 
Sjogren syndrome 
3062/11178 7 OR 4.25 (2.67-6.76) < 10-6 1.02-2.77 72 No/NE II 3 
Dokras, 2011  Polycystic ovary syndrome 522/475 10 OR 4.03 (2.96-5.49) < 10-6 2.80-5.80 0 No/No Weak 4 
Osborn, 2014  Traumatic brain injury NA 16 OR 3.41 (2.40-4.84) < 10-6 1.28-9.13 50 No/Yes Weak 3 
Fiest, 2013  Epilepsy (current 
depression) 
1632/79762 3 OR 3.12 (1.70-5.73) > 10-6 but < 10-3 0.00-6085.29 91 No/No III 8 
Atlantis, 2012  Sexual dysfunction 5488/5683 6 OR 2.71 (1.93-3.79) < 10-6 1.13-6.50 41 No/No I 8 
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Reference Risk factor 
Total number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 95% PI I
2
 
Small-
study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Baglioni, 2011  Insomnia NA 21 OR 2.60 (1.98-3.42) < 10-6 0.79-8.57 84 Yes/No III 4 
Atlantis, 2013  COPD/chronic lung 
disease 
297031/7128500 4 RR 2.38 (1.47-3.85) > 10-6 but < 10-3 0.31-18.45 78 Yes/No III 6 
Wan, 2016  Dry eye disease without 
Sjogren syndrome 
611517/2927706 6 OR 2.24 (1.50-3.34) < 0.001 0.88-2.41 99 No/No III 3 
Dowlatshahi, 2014  Psoriasis 86945/271291 9 OR 1.64 (1.41-1.90) < 10-6 1.07-2.51 84 No/No II 6 
Gilbody, 2007  Low folate 1769/13446 10 OR 1.54 (1.09-2.20) 0.016 0.59-4.05 50 No/No Weak 7 
Cheungpasitporn, 2015  Hypomagnesaemia NA 6 RR 1.34 (1.01-1.79) 0.046 0.68-2.64 33 Yes/No Weak 7 
Hasan, 2015  Diabetes  NA 16 RR 1.25 (1.17-1.34) < 10-6 1.03-1.52 59 No/NE Weak 4 
Mitchell, 2013  Long-term cancer survivor 
(vs. HCs) 
NA 13 RR 1.17 (0.95-1.45) 0.142 0.55-2.51 87 No/No NS 8 
Diprose, 2016  Psychogenic nonepileptic 
seizures (vs. epilepsy) 
196/228 7 RR 1.15 (0.85-1.57) 0.365 0.65-2.04 14 No/No NS 2 
Obesity and metabolic abnormalities 
Jokela, 2014  4 or 5 metabolic risk 
factors 
1191/9586 8 OR 2.06 (1.59-2.68) < 10-6 1.19-3.56 24 No/No I 3 
Jokela, 2014  3 metabolic risk factors 3014/9586 8 OR 1.99 (1.60-2.48) < 10-6 1.20-3.30 35 Yes/No II 3 
Luppino, 2010  Obesity (prospective 
studies) 
NA 8 OR 1.55 (1.22-1.98) > 10-6 but < 10-3 0.86-2.79 38 No/No III 7 
Pan, 2012  Metabolic syndrome 
(prospective studies) 
2316/27034 9 OR 1.48 (1.17-1.87) 0.001 0.74-2.95 61 No/Yes Weak 6 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
41 
 
Reference Risk factor 
Total number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 95% PI I
2
 
Small-
study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Jokela, 2014  2 metabolic risk factors 6691/9586 8 OR 1.45 (1.17-1.80) > 10-6 but < 10-3 0.83-2.54 51 Yes/No III 3 
Pan, 2012  Metabolic syndrome  20924/132380 27 OR 1.42 (1.28-1.57) < 10-6 0.97-2.07 55 No/No II 6 
Jokela, 2014  Obesity 7673/11413 8 OR 1.35 (1.21-1.50) < 10-6 1.18-1.54 0 No/No I 3 
Jokela, 2014  1 metabolic risk factor 9855/9586 8 OR 1.32 (1.06-1.65) 0.014 0.72-2.42 60 Yes/No Weak 3 
Tong, 2016  Previously diagnosed 
diabetes vs. normal 
glucose metabolism 
NA 6 RR 1.29 (1.03-1.62) 0.026 0.88-2.41 49 No/NE Weak 9 
Luppino, 2010  Overweight (prospective 
studies) 
NA 7 OR 1.27 (1.07-1.50) 0.007 0.92-1.74 14 No/No Weak 7 
Chen, 2016  Undiagnosed diabetes vs. 
Normal glucose 
metabolism 
27579/226971 14 OR 1.27 (1.02-1.59) 0.034 0.94-2.56 77 No/Yes Weak 7 
Nouwen, 2010  Type 2 diabetes mellitus 37964/131033 11 OR 1.24 (1.09-1.40) > 10-6 but < 10-3 0.86-1.77 68 No/No III 6 
de Wit, 2010  Obesity (community 
samples) 
NA 16 OR 1.21 (0.96-1.52) 0.103 0.47-3.12 95 Yes/No NS 4 
Chen, 2016  Pre-diabetes vs. normal 
glucose metabolism 
63349/194031 19 OR 1.11 (1.03-1.19) 0.009 0.32-1.38 48 No/Yes Weak 7 
Tong, 2016  Newly diagnosed diabetes 
vs. normal glucose 
metabolism 
NA 6 RR 1.07 (0.74-1.55) 0.726 1.02-2.77 42 No/NE NS 9 
Jokela, 2014  Overweight 11251/11413 8 OR 1.01 (0.91-1.11) 0.880 0.89-1.14 0 No/No NS 3 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
42 
 
Reference Risk factor 
Total number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 95% PI I
2
 
Small-
study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Nouwen, 2011  Impaired glucose 
metabolism 
6236/26722 11 OR 0.95 (0.85-1.07) 0.441 0.74-1.23 25 No/No NS 5 
Pregnancy and birth-related 
Loret de Mola, 2014  Low birth weight (≤ 2500 
g) 
NA 21 OR 1.38 (1.16-1.65) > 10-6 but < 10-3 0.89-2.14 24 No/No III 5 
Loret de Mola, 2014  Small for gestacional age NA 5 OR 1.14 (0.64-2.03) 0.656 0.20-6.36 49 No/No NS 5 
Loret de Mola, 2014  Premature birth NA 8 OR 1.08 (0.77-1.52) 0.662 0.45-2.57 48 No/No NS 5 
Sociodemographic factors 
Lorant, 2003  Low socioeconomic status NA 56 OR 1.87 (1.62-2.16) < 10-6 0.73-4.78 87 Yes/NE Weak 6 
Madsen, 2017  Job strain 1909/25552 7 OR 1.77 (1.46-2.13) < 10-6 1.02-14.01 24 No/No I 7 
Kim, 2016  Insecurely employed vs. 
securely employed 
795/3903 6 OR 1.29 (1.06-1.57) 0.010 0.66-2.53 89 No/Yes Weak 6 
Madsen, 2017  Job strain 982/119229 14 HR 1.27 (1.04-1.55) 0.019 0.88-7.32 25 No/Yes Weak 7 
Kisely, 2017  Indigenous vs. other 
populations 
4843/57988 8 OR 1.24 (0.63-2.44) 0.536 0.11-13.60 97 No/NE NS 8 
Kim, 2016  Employed vs. unemployed 40679/1836 13 OR 1.16 (1.09-1.23) < 0.001 0.96-1.40 69 Yes/Yes III 6 
Tarricone, 2012  Ethnical group (minority 
vs. predominant) 
13569/32646 19 RR 1.15 (1.00-1.33) 0.050 0.65-2.04 86 No/No NS 4 
Richardson, 2015  Neighborhood 
socioeconomic conditions 
NA 10 OR 1.12 (1.01-1.24) 0.029 0.82-1.53 80 No/No Weak 7 
Watanabe, 2016  Overtime work 432/12990 5 RR 1.05 (0.68-1.61) 0.829 0.28-3.95 54 No/No NS 5 
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Reference Risk factor 
Total number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 95% PI I
2
 
Small-
study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Puthran, 2016  Medical students vs. non-
medical students 
NA 6 OR 0.96 (0.65-1.43) 0.857 0.25-3.67 85 Yes/NE NS 7 
Trauma and disasters 
Mandelli, 2015  Emotional abuse in 
childhood 
4112/12337 8 OR 2.78 (1.89-4.09) < 10-6 0.74-10.46 91 No/No II 7 
Mandelli, 2015  Neglect in childhood 1668/3620 6 OR 2.75 (1.59-4.74) > 10-6 but < 10-3 0.40-19.06 92 Yes/No III 7 
Chen, 2010  Lifetime exposure to 
sexual abuse 
503/2768 11 OR 2.64 (1.92-3.65) < 10-6 1.03-6.77 68 No/No Weak 9 
Mandelli, 2015  Sexual abuse in childhood 4586/13915 14 OR 2.42 (1.94-3.02) < 10-6 1.19-4.94 69 No/No II 7 
Blore, 2015  Gulf-war veterans (vs. 
non-deployed personnel) 
16826/13136 11 OR 2.37 (1.91-2.93) < 10-6 1.20-4.67 76 No/No II 5 
Bonde, 2016  Natural disaster NA 5 OR 2.14 (1.18-3.89) 0.013 0.23-19.66 94 No/Yes Weak 8 
Bonde, 2016  Terrorist act NA 6 OR 2.02 (1.38-2.96) > 10-6 but < 10-3 0.57-7.16 82 No/No III 8 
Mandelli, 2015  Physical abuse in 
childhood 
3886/12952 10 OR 1.98 (1.68-2.33) < 10-6 1.33-2.94 42 No/No I 7 
Ttofi, 2011  Bullying victimization 
during school 
NA 20 OR 1.74 (1.54-1.97) < 10-6 1.13-2.68 58 No/NE Weak 5 
Bonde, 2016  Military deployment NA 7 OR 1.66 (1.10-2.49) 0.015 0.38-7.29 99 No/No Weak 8 
Abbreviations: CI = confidence interval; NA = not available; NE = not evaluated due to lack of datasets or individual study information for power calculations; EPA = eicosapentaenoic acid; DHA 
= docosahexaenoic acid; HSV-1 = herpes simplex virus type I; HHV-1 = human herpesvirus 1; COPD = chronic pulmonary obstructive disease 
*Evidence classification: I = convincing evidence criteria (P < 10-6 per random-effects model; over than 1000 cases; no excess of significance bias; no small studies effects; small heterogeneity; 
prediction interval not including the null); II = highly-suggestive evidence criteria (not meeting type I criteria, but having P < 10-6 per random-effects model; over than 1000 cases; effect size of the 
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largest study not crossing the null); III = suggestive evidence criteria (not meeting type I or II criteria, but having P < 10-3 per random-effects model; over than 1000 cases); weak evidence criteria 
(all other associations with P < 0.05 per random-effects model); NS = non-significant associations; NE = not evaluated due to lack of individual study information  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
45 
 
Table 2. Characteristics, assessment of epidemiological credibility, and methodological quality assessment of 39 eligible meta-analyses of environmental 
risk factors for late-life depression 
Reference Risk factor 
Total 
number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 95% PI I
2
 
Small-study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Dietary factors 
Petridou, 2016  Low B12 NA 8 OR 1.25 (0.97-1.59) 0.080 0.68-2.29 40 No/No NS 4 
Petridou, 2016  Low folate NA 11 OR 1.21 (0.98-1.49) 0.079 0.71-2.05 37 No/No NS 4 
Family factors 
Yan, 2011  Marital status (widowed, 
divorced, never married vs. 
married) 
515/539 8 RR 1.36 (1.01-1.84) 0.042 0.51-3.61 81 No/NE Weak 4 
Medical history and comorbid diseases 
Chang-Quan, 2010  Poor health  8630/16552 11 OR 4.08 (3.25-5.12) < 10-6 1.88-8.84 83 No/No II 4 
Bao, 2017  Persistent sleep disturbances 674/1872 4 RR 3.87 (2.45-6.12) < 10-6 0.90-16.61 27 No/Yes Weak 8 
Chang-Quan, 2010  Chronic disease  9090/15321 10 OR 2.59 (1.78-3.76) < 10-6 0.65-10.30 95 No/No II 4 
Cole, 2003  Prior depression 623/3667 3 OR 2.49 (1.55-4.01) > 10-6 but < 10-3 0.01-510.34 71 Yes/No Weak 5 
Huang, 2010  Arthritis  2269/6491 6 OR 2.27 (1.35-3.82) 0.002 0.37-13.85 88 No/No Weak 6 
Huang, 2010  Kidney disease  67/1872 3 OR 2.22 (1.31-3.76) 0.003 0.07-67.38 0 No/No Weak 6 
Huang, 2010  Urologic problems  150/1492 3 OR 2.19 (1.52-3.15) > 10-6 but < 10-3 0.20-23.32 0 No/No Weak 6 
Huang, 2010  Chronic lung disease  646/2263 4 OR 2.14 (0.97-4.74) 0.060 0.06-78.35 84 No/No NS 6 
Huang, 2010  Gastrointestinal disease  166/2653 4 OR 1.95 (0.80-4.72) 0.140 0.04-84.40 75 No/No NS 6 
Huang, 2010  Poor vision  11066/20976 12 OR 1.94 (1.67-2.25) < 10-6 1.32-2.86 54 No/No II 6 
Bao, 2017  Sleep disturbances 2610/3545 11 RR 1.92 (1.59-2.33) < 10-6 1.39-2.66 10 No/Yes II 8 
Huang, 2010  Stroke  646/5283 9 OR 1.87 (1.33-2.62) > 10-6 but < 10-3 0.66-5.31 66 No/No Weak 6 
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Reference Risk factor 
Total 
number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 
95% PI I2 
Small-study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Huang, 2010  Cardiac disease  1911/10134 6 OR 1.81 (1.41-2.31) > 10-6 but < 10-3 0.91-3.60 56 No/No III 6 
Huang, 2010  Poor hearing  4448/13319 7 OR 1.71 (1.28-2.27) > 10-6 but < 10-3 0.75-3.91 79 No/No III 6 
Chang-Quan, 2010  Chronic disease (prospective 
studies) 
1056/8755 8 RR 1.53 (1.20-1.96) > 10-6 but < 10-3 0.72-3.25 68 No/NE III 4 
Agtmaal, 2017  Cerebral microinfarction NA 4 OR 1.43 (1.22-1.68) < 0.001 0.98-2.10 2 Yes/NE Weak 8 
Huang, 2010  Hypertension  762/3348 5 OR 1.28 (0.96-1.72) 0.096 0.53-3.08 57 No/No NS 6 
Agtmaal, 2017  White matter hyperintensities NA 30 OR 1.24 (1.15-1.34) < 10-6 1.39-2.66 67 Yes/NE Weak 8 
Agtmaal, 2017  Cerebral microbleeds NA 4 OR 1.18 (1.03-1.35) 0.015 0.88-1.58 0 No/NE Weak 8 
Huang, 2010  Cancer survivors  310/2371 5 OR 0.87 (0.61-1.25) 0.463 0.49-1.57 0 No/No NS 6 
Obesity and metabolic factors 
Huang, 2010  Diabetes  1814/6804 9 OR 1.88 (1.31-2.70) > 10-6 but < 10-3 0.57-6.25 82 No/Yes III 6 
Huang, 2010  Diabetes (prospective studies) 518/1009 3 RR 1.50 (0.92-2.44) 0.107 0.01-402.35 71 No/NE NS 6 
Sociodemographic factors 
Zhao, 2012  Age > 70 (prospective studies) 442/4980 4 RR 5.92 (0.52-66.86) 0.150 0.00-
819558.94 
99 No/No NS 5 
Xiu-Ying, 2012  Live in nursing home 
(prospective studies) 
272/1927 3 RR 1.94 (1.18-3.18) 0.009 0.01-362.10 56 No/NE Weak 5 
Cole, 2003  Lower education 619/5759 4 OR 1.79 (1.14-2.80) 0.011 0.27-12.02 73 Yes/Yes Weak 5 
Zhao, 2012  Age > 80  621/8326 3 RR 1.64 (1.36-1.98) < 10-6 0.47-5.67 1 No/No Weak 5 
Zhao, 2012  Age > 65 15017/7004 6 OR 1.63 (1.24-2.16) > 10-6 but < 10-3 0.61-4.35 90 No/Yes III 5 
Chang-Quan, 2010  Low educational level  16590/24067 24 OR 1.58 (1.38-1.82) < 10-6 0.89-2.83 74 No/No II 4 
Xiu-Ying, 2012  Living alone 10478/23612 16 OR 1.55 (1.23-1.95) > 10-6 but < 10-3 0.64-3.72 76 No/No III 5 
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Reference Risk factor 
Total 
number of 
cases/ 
controls 
Number 
of 
primary 
studies 
Effect 
size 
metric 
Random effects 
summary effect 
size (95% CI) 
P (by random 
effects) 
95% PI I2 
Small-study 
effects/ 
excess 
statistical 
significance 
Level of 
evidence* 
AMSTAR 
Zhao, 2012  Age > 85  4559/19039 12 OR 1.52 (1.20-1.93) > 10-6 but < 10-3 0.68-3.38 73 No/No III 5 
Chang-Quan, 2010  Low educational level 
(prospective studies) 
3957/6374 12 RR 1.49 (1.16-1.91) 0.002 0.64-3.49 75 No/NE Weak 4 
Zhao, 2012  Age > 75  11219/20534 19 OR 1.35 (1.17-1.56) > 10-6 but < 10-3 0.76-2.39 76 No/No III 5 
Xiu-Ying, 2012  Living alone (prospective 
studies) 
591/754 4 RR 1.27 (0.90-1.79) 0.180 0.45-3.59 21 No/NE NS 5 
Zhao, 2012  Age > 70  11875/10650 6 OR 1.22 (0.97-1.52) 0.089 0.56-2.64 87 No/No NS 5 
Cole, 2003  Unmarried 782/6839 5 OR 1.01 (0.83-1.22) 0.950 0.64-1.59 22 No/No NS 5 
Trauma and disasters 
Cole, 2003  Recent bereavement 713/7507 3 OR 3.95 (3.06-5.08) < 10-6 0.61-25.51 10 No/No Weak 5 
Abbreviations: CI = confidence interval; NA = not available; NE = not evaluated due to lack of datasets or individual study information for power calculation 
*
 Evidence classification: I = convincing evidence criteria (P < 10-6 per random-effects model; over than 1000 cases; no excess of significance bias; no small studies effects; small heterogeneity; 
prediction interval not including the null); II = highly-suggestive evidence criteria (not meeting type I criteria, but P < 10-6 per random-effects model; over than 1000 cases; effect size of the largest 
study not crossing the null); III = suggestive evidence criteria (not meeting type I or II criteria, but P < 10-3 per random-effects model; over than 1000 cases); weak evidence criteria (all other 
associations with P < 0.05 per random-effects model); NS = non-significant associations; NE = not evaluated due to lack of individual study information. 
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Table 3. Risk factors for depression reported in Mendelian randomization studies 
Risk factor 
(Reference) 
Population 
Sample size/ 
Number of events 
(Number of studies)* 
Genetic 
instruments 
(GI) 
Variance (R2) 
explained by 
GI (%) 
Type of 
metric 
Estimate of effect 
(95% CI) 
P value 
Statistical 
power 
Alcohol consumption 
(Almeida, 2014)  
Australia 3873/610 (DS) ADH1B 
rs1229984 
0.11 OR GA = 0.99 (0.70, 1.40) 
AA = 1.65 (0.54, 5.08) 
0.946 0.05 
0.07 
Smoking* 
(Taylor, 2014)  
United Kingdom/ 
Switzerland/ 
Denmark/ 
Norway/ 
USA/ 
Netherlands/ 
Canada 
82608/9229 (9) 
(DEP or DS) 
CHRNA5 
rs16969968 
and 
CHRNA3 
rs1051730 
NA OR Never smokers = 1.01 (0.96, 1.06) 
Former smokers = 1.02 (0.96, 1.08) 
Current smokers = 1.01 (0.95, 1.07) 
Ever smokers = 1.02 (0.98, 1.06) 
 
0.788 
0.564 
0.756 
0.346 
NA 
Obesity 
(Hung, 2014)  
USA/United 
Kingdom/Europe 
3222/2430 (3) (DEP) FTO 
rs3751812 
NA β -0.03 (-0.18, 0.13) 0.730 NA 
Obesity 
(Hung, 2014)  
USA/United 
Kingdom/Europe 
3222/2430 (3) (DEP) wGRS from 32 
SNPS 
associated to 
BMI in GWAS 
studies 
NA β -0.02 (-0.11, 0.07) 0.620 NA 
Body-mass index (BMI)** 
(Hartwig, 2016)  
USA/United 
Kingdom/Europe/ 
Australia 
9240/9519 (DEP) 90 BMI-
associated 
SNPs 
NA OR IVW = 1.15 (0.92, 1.44) 
Weighted median = 1.40 (1.03, 1.90) 
MR-Egger = 1.28 (0.74, 2.24) 
MR-Egger (SIMEX) = 1.33 (0.72, 2.47) 
0.221 
0.035 
0.374 
0.364 
NA 
Body-mass index (BMI)** 
(Hartwig, 2016)  
USA/United 
Kingdom/Europe/ 
9240/9519 (DEP) 86 SNPs non-
influential on 
NA OR IVW = 1.25 (1.02, 1.52) 
Weighted median = 1.45 (1.05, 1.99) 
0.030 
0.026 
NA 
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Australia BMI*** MR-Egger = 1.52 (0.93, 2.49) 
MR-Egger (SIMEX) = 1.60 (0.93, 2.75) 
0.094 
0.087 
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Age of menarche 
(continuous genetic instrument) 
(Sequeira, 2017)  
United Kingdom 2404 (DS at 14yo) nwGRS from 
123 SNPSs 
associated with 
menarche in 
GWAS 
NA OR 1.020 (1.005, 1.04) 0.010 NA 
2145 (DS at 17 yo) 1.002 (0.99, 1.02) 0.780 NA 
1570 (DS at 19 yo) 1.001 (0.98, 1.02) 0.880 NA 
1910 (DEP at 18 yo) 1.004 (0.98, 1.03) 0.730 NA 
Age of menarche 
(categorical genetic instrument) 
(Sequeira, 2017)  
United Kingdom 2404 (DS at 14yo) nwGRS from 
123 SNPs 
associated with 
menarche in 
GWAS (2nd, 
3rd and 4th 
quartiles vs. 1st 
quartile) 
NA OR 1.62 (1.18, 2.25) 
1.38 (0.99, 1.92) 
1.74 (1.26, 2.40) 
0.003 
0.050 
0.001 
NA 
2145 (DS at 17 yo) 0.95 (0.71, 1.26) 
0.90 (0.68, 1.21) 
1.08 (0.82, 1.43) 
0.730 
0.490 
0.590 
NA 
1570 (DS at 19 yo) 0.74 (0.52, 1.04) 
0.81 (0.58, 1.12) 
1.06 (0.76, 1.46) 
0.080 
0.200 
0.740 
NA 
1910 (DEP at 18 yo) 0.84 (0.55, 1.28) 
0.83 (0.54, 1.26) 
1.14 (0.76, 1.70) 
0.410 
0.370 
0.530 
NA 
Tobacco smoking 
(Wium-Andersen, 2015)   
Denmark 40014/771 (CDD)  CHRNA3 gene 
cluster 
rs1051730 
0.4 OR CT = 1.02 (0.88, 1.18) 
TT = 0.85 (0.66, 1.10) 
0.440 0.05 
0.06 
Alcohol consumption 
(Wium-Andersen, 2015)  
Denmark 78154/1106 (CDD) ADH1B 
rs1229984 and 
ADH1C rs698 
genotype 
combinations 
(2 vs. 1, 
3 vs. 1, 
0.12 OR 1.18 (0.85, 1.63) 0.060 0.05 
1.10 (0.80, 1.53) 0.05 
1.40 (1.00, 1.96) 0.07 
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4 vs. 1) 
Coffee consumption 
(Kwok, 2016)  
USA/United 
Kingdom/Europe/ 
Australia 
9240/9519 (DEP) Genome-wide 
significant 
SNPs# 
NA OR 0.89 (0.66, 1.21) 0.451 NA 
Coffee consumption 
(Kwok, 2016)  
USA/United 
Kingdom/Europe/ 
Australia 
9240/9519 (DEP) 3 SNPs 
functionally 
relevant to 
coffee 
metabolism 
(rs4410790, 
rs2472297 and 
rs2470893) 
NA OR 0.95 (0.47, 1.91) 0.886 NA 
Abbreviations: DS = depression assessed by a screening instrument with a cutoff score; DEP = depression diagnosed with structured interview; CDD = clinical diagnosis based on ICD criteria 
for depression; nwGRS = non-weighted genetic risk score; wGRS = weighted genetic risk score 
*Mendelian randomisation meta-analysis of the studies from the CARTA (Consortium for Causal Analysis Research in Tobacco and Alcohol) consortium. Only datasets 1958 British Cohort, 
CoLaus, ELSA, Generation Scotland, HBCS, HUNT, NHANES, Rotterdam and SYS-P from the original meta-analysis were eligible according to the depression definition adopted in this 
umbrella review and were used to recalculate the summary effect size. Summary ORs are presented for each smoking exposure category and were calculated using a fixed-effects model. ORs 
are expressed per minor allele of the SNP. 
**This study used three different methods to assess the association of the genetic instrument and depression: inverse variance weighting (IVW), weighted median and MR-Egger regression (with 
and without simulation extrapolation – SIMEX). The MR-Egger method accounts for violations of instrumental variable assumptions, and the SIMEX procedure corrects for regression dilution. 
All three methods should provide directionally consistent estimates. 
***Non-influential SNPs were selected by excluding SNPs that were highly associated in the analysis with all 90 SNPs using tests of influence based on regression residuals. 
#SNPs included were rs6265, rs17685, rs1260326, rs1481012, rs2470893, rs2472297, rs4410790, rs7800944 and rs9902453; SNPs without known pleiotropy included for analyses were rs17685, 
rs2470893, rs2472297, rs4410790 and rs9902453. 
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Records identified through 
database searching 
(n = 7790) 
Sc
re
en
in
g 
In
cl
u
d
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El
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ty
 
Id
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ti
fi
ca
ti
o
n
 
Additional records identified 
through other sources 
(n = 0) 
Records after duplicates removed 
(n = 5869) 
Records screened 
(n = 5869) 
Records excluded 
(n = 5409) 
Full-text articles assessed 
for eligibility 
(n = 460) 
Full-text articles excluded, 
with reasons 
(n = 382) 
 176 Not a meta-analysis 
 51 Depressive symptoms (no 
cutoff score) 
 51 Did not investigate an 
association with MDD 
 21 Not MDD 
 19 Not English 
 16 Association investigated in 
another meta-analysis with 
more datasets  
 16 Risk factor for MDD in a 
specific condition 
 11 Not peer-reviewed article 
 6 MDD as a risk factor for a 
disease 
 5 Insufficient data or less than 
3 datasets  
 4 MA of intervention studies 
 3 Factor related to MDD 
recurrence/relapse 
 1 MA related to MDD severity 
 1 MA of biomarker for MDD 
 1 Overlapping MR sample 
Studies included in 
qualitative synthesis 
(n = 78) 
Studies included in 
quantitative synthesis  
(n = 78) 
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Depression - Type I
Obesity
4 or 5 metabolic risk factors
Widowhood
Childhood physical abuse
Tea intake
Sexual dysfunction
Dietary zinc
Job strain
Depression - Type II
Intimate partner violence against women
Metabolic syndrome
#
Gulf-war veterans (vs. non-deployed personnel)
3 metabolic risk factors
Psoriasis
Childhood emotional abuse
Childhood sexual abuse
Sedentary behavior
Dry eye disease with Sjögren syndrome
Late-life depression - Type II
Low educational level
Poor health
Chronic disease
Poor vision
Sleep disturbances
Pediatric depression - Type II
Asthma
1.35 (1.21, 1.50)
2.06 (1.59, 2.68)
5.59 (3.79, 8.23)
1.98 (1.68, 2.33)
0.68 (0.61, 0.77)
2.71 (1.93, 3.79)
0.65 (0.57, 0.75)
1.27 (1.04, 1.55)
2.57 (2.25, 2.94)
1.42 (1.28, 1.57)
2.37 (1.91, 2.93)
1.99 (1.60, 2.48)
1.64 (1.41, 1.90)
2.78 (1.89, 4.09)
2.42 (1.94, 3.02)
1.25 (1.16, 1.35)
4.25 (2.67, 6.76)
1.58 (1.38, 1.82)
4.08 (3.25, 5.12)
2.59 (1.78, 3.76)
1.94 (1.67, 2.25)
1.92 (1.59, 2.33)
2.08 (1.56, 2.77)
ES (95% CI)
  
1.25 .5 2 4
